STEPAN CO (SCL) Stock Fundamental Analysis

NYSE:SCL • US8585861003

51.33 USD
+0.79 (+1.56%)
At close: Feb 26, 2026
51.33 USD
0 (0%)
After Hours: 2/26/2026, 8:04:00 PM
Fundamental Rating

4

SCL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. Both the profitability and financial health of SCL have multiple concerns. SCL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year SCL was profitable.
  • SCL had a positive operating cash flow in the past year.
  • Each year in the past 5 years SCL has been profitable.
  • SCL had a positive operating cash flow in 4 of the past 5 years.
SCL Yearly Net Income VS EBIT VS OCF VS FCFSCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.86%, SCL is in line with its industry, outperforming 59.04% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 3.63%, SCL is in the better half of the industry, outperforming 60.24% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 3.55%, SCL is in line with its industry, outperforming 51.81% of the companies in the same industry.
Industry RankSector Rank
ROA 1.86%
ROE 3.63%
ROIC 3.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SCL Yearly ROA, ROE, ROICSCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • SCL has a Profit Margin of 1.96%. This is comparable to the rest of the industry: SCL outperforms 59.04% of its industry peers.
  • SCL's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 3.29%, SCL is doing worse than 62.65% of the companies in the same industry.
  • SCL's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 11.94%, SCL is not doing good in the industry: 79.52% of the companies in the same industry are doing better.
  • SCL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.29%
PM (TTM) 1.96%
GM 11.94%
OM growth 3Y-26.77%
OM growth 5Y-20.39%
PM growth 3Y-27.63%
PM growth 5Y-21.58%
GM growth 3Y-9.08%
GM growth 5Y-10.82%
SCL Yearly Profit, Operating, Gross MarginsSCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SCL is destroying value.
  • There is no outstanding debt for SCL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SCL Yearly Shares OutstandingSCL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SCL Yearly Total Debt VS Total AssetsSCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.48 indicates that SCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • SCL's Altman-Z score of 2.48 is fine compared to the rest of the industry. SCL outperforms 67.47% of its industry peers.
  • SCL has a debt to FCF ratio of 20.43. This is a negative value and a sign of low solvency as SCL would need 20.43 years to pay back of all of its debts.
  • SCL's Debt to FCF ratio of 20.43 is in line compared to the rest of the industry. SCL outperforms 48.19% of its industry peers.
  • SCL has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.29, SCL is in the better half of the industry, outperforming 77.11% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 20.43
Altman-Z 2.48
ROIC/WACC0.31
WACC11.47%
SCL Yearly LT Debt VS Equity VS FCFSCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.30 indicates that SCL should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.30, SCL is not doing good in the industry: 84.34% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.84 indicates that SCL may have some problems paying its short term obligations.
  • SCL has a worse Quick ratio (0.84) than 77.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.84
SCL Yearly Current Assets VS Current LiabilitesSCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • SCL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.27%.
  • The earnings per share for SCL have been decreasing by -20.33% on average. This is quite bad
  • SCL shows a small growth in Revenue. In the last year, the Revenue has grown by 6.96%.
  • The Revenue has been growing slightly by 4.52% on average over the past years.
EPS 1Y (TTM)-17.27%
EPS 3Y-35.11%
EPS 5Y-20.33%
EPS Q2Q%-116.67%
Revenue 1Y (TTM)6.96%
Revenue growth 3Y-5.61%
Revenue growth 5Y4.52%
Sales Q2Q%5.38%

3.2 Future

  • The Earnings Per Share is expected to grow by 60.47% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, SCL will show a small growth in Revenue. The Revenue will grow by 5.88% on average per year.
EPS Next Y95.06%
EPS Next 2Y60.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.14%
Revenue Next 2Y6.39%
Revenue Next 3Y7.13%
Revenue Next 5Y5.88%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SCL Yearly Revenue VS EstimatesSCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
SCL Yearly EPS VS EstimatesSCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

  • SCL is valuated quite expensively with a Price/Earnings ratio of 28.20.
  • The rest of the industry has a similar Price/Earnings ratio as SCL.
  • The average S&P500 Price/Earnings ratio is at 27.21. SCL is around the same levels.
  • A Price/Forward Earnings ratio of 14.46 indicates a correct valuation of SCL.
  • 67.47% of the companies in the same industry are more expensive than SCL, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.13. SCL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 28.2
Fwd PE 14.46
SCL Price Earnings VS Forward Price EarningsSCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 73.49% of the companies in the same industry are more expensive than SCL, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SCL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 36.2
EV/EBITDA 8.5
SCL Per share dataSCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SCL's earnings are expected to grow with 60.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y60.47%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • SCL has a Yearly Dividend Yield of 3.13%.
  • SCL's Dividend Yield is a higher than the industry average which is at 2.21.
  • SCL's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 3.13%

5.2 History

  • The dividend of SCL is nicely growing with an annual growth rate of 8.06%!
  • SCL has paid a dividend for at least 10 years, which is a reliable track record.
  • SCL has decreased its dividend recently.
Dividend Growth(5Y)8.06%
Div Incr Years1
Div Non Decr Years1
SCL Yearly Dividends per shareSCL Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 76.82% of the earnings are spent on dividend by SCL. This is not a sustainable payout ratio.
  • SCL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP76.82%
EPS Next 2Y60.47%
EPS Next 3YN/A
SCL Yearly Income VS Free CF VS DividendSCL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M
SCL Dividend Payout.SCL Dividend Payout, showing the Payout Ratio.SCL Dividend Payout.PayoutRetained Earnings

STEPAN CO

NYSE:SCL (2/26/2026, 8:04:00 PM)

After market: 51.33 0 (0%)

51.33

+0.79 (+1.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-23
Earnings (Next)04-27
Inst Owners86.79%
Inst Owner Change-2.09%
Ins Owners5.55%
Ins Owner Change5.11%
Market Cap1.16B
Revenue(TTM)2.33B
Net Income(TTM)45.24M
Analysts80
Price Target76.5 (49.04%)
Short Float %1.62%
Short Ratio1.87
Dividend
Industry RankSector Rank
Dividend Yield 3.13%
Yearly Dividend1.51
Dividend Growth(5Y)8.06%
DP76.82%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-02
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.76%
Min EPS beat(2)-42.79%
Max EPS beat(2)-22.72%
EPS beat(4)1
Avg EPS beat(4)-24.99%
Min EPS beat(4)-65.06%
Max EPS beat(4)30.63%
EPS beat(8)3
Avg EPS beat(8)-1.9%
EPS beat(12)4
Avg EPS beat(12)-8.59%
EPS beat(16)7
Avg EPS beat(16)-1.91%
Revenue beat(2)0
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-1.58%
Max Revenue beat(2)-1.55%
Revenue beat(4)1
Avg Revenue beat(4)0.44%
Min Revenue beat(4)-1.58%
Max Revenue beat(4)5.27%
Revenue beat(8)1
Avg Revenue beat(8)-2.38%
Revenue beat(12)2
Avg Revenue beat(12)-3.48%
Revenue beat(16)6
Avg Revenue beat(16)-0.7%
PT rev (1m)-11.76%
PT rev (3m)-11.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.14%
EPS NY rev (1m)0%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 28.2
Fwd PE 14.46
P/S 0.5
P/FCF 36.2
P/OCF 7.43
P/B 0.93
P/tB 1.05
EV/EBITDA 8.5
EPS(TTM)1.82
EY3.55%
EPS(NY)3.55
Fwd EY6.92%
FCF(TTM)1.42
FCFY2.76%
OCF(TTM)6.9
OCFY13.45%
SpS101.85
BVpS55.12
TBVpS48.93
PEG (NY)0.3
PEG (5Y)N/A
Graham Number47.51
Profitability
Industry RankSector Rank
ROA 1.86%
ROE 3.63%
ROCE 4.4%
ROIC 3.55%
ROICexc 3.82%
ROICexgc 4.18%
OM 3.29%
PM (TTM) 1.96%
GM 11.94%
FCFM 1.39%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-26.77%
OM growth 5Y-20.39%
PM growth 3Y-27.63%
PM growth 5Y-21.58%
GM growth 3Y-9.08%
GM growth 5Y-10.82%
F-Score4
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 20.43
Debt/EBITDA 1.81
Cap/Depr 101.87%
Cap/Sales 5.39%
Interest Coverage 2.64
Cash Conversion 79.05%
Profit Quality 70.9%
Current Ratio 1.3
Quick Ratio 0.84
Altman-Z 2.48
F-Score4
WACC11.47%
ROIC/WACC0.31
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.27%
EPS 3Y-35.11%
EPS 5Y-20.33%
EPS Q2Q%-116.67%
EPS Next Y95.06%
EPS Next 2Y60.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.96%
Revenue growth 3Y-5.61%
Revenue growth 5Y4.52%
Sales Q2Q%5.38%
Revenue Next Year8.14%
Revenue Next 2Y6.39%
Revenue Next 3Y7.13%
Revenue Next 5Y5.88%
EBIT growth 1Y6.39%
EBIT growth 3Y-30.88%
EBIT growth 5Y-16.79%
EBIT Next Year199.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.03%
OCF growth 3YN/A
OCF growth 5YN/A

STEPAN CO / SCL FAQ

What is the fundamental rating for SCL stock?

ChartMill assigns a fundamental rating of 4 / 10 to SCL.


Can you provide the valuation status for STEPAN CO?

ChartMill assigns a valuation rating of 5 / 10 to STEPAN CO (SCL). This can be considered as Fairly Valued.


Can you provide the profitability details for STEPAN CO?

STEPAN CO (SCL) has a profitability rating of 3 / 10.


What is the financial health of STEPAN CO (SCL) stock?

The financial health rating of STEPAN CO (SCL) is 3 / 10.


How sustainable is the dividend of STEPAN CO (SCL) stock?

The dividend rating of STEPAN CO (SCL) is 6 / 10 and the dividend payout ratio is 76.82%.